Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Biologics
1
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study
8/31/2022 11:27:52 AM |
Browse: 327 |
Download: 983
2
Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
7/27/2022 1:17:37 PM |
Browse: 206 |
Download: 372
3
Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
6/16/2022 1:07:50 PM |
Browse: 361 |
Download: 1042
4
Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
3/30/2022 3:20:26 PM |
Browse: 351 |
Download: 562
5
Association of cancer with comorbid inflammatory conditions and treatment in patients with Lynch syndrome
1/22/2022 6:17:12 AM |
Browse: 309 |
Download: 531
6
Orphan patients with inflammatory bowel disease - when we treat beyond evidence
12/17/2021 8:56:01 AM |
Browse: 342 |
Download: 500
7
Approach to medical therapy in perianal Crohn’s disease
7/6/2021 2:31:17 AM |
Browse: 341 |
Download: 444
8
Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
1/21/2019 9:20:19 AM |
Browse: 901 |
Download: 1119
9
Biosimilars: Review of current applications, obstacles, and their future in medicine
8/16/2018 11:54:24 AM |
Browse: 835 |
Download: 897
10
Thiopurines are negatively associated with anthropometric parameters in pediatric Crohn’s disease
5/11/2018 10:51:26 AM |
Browse: 896 |
Download: 1279
11
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?
9/21/2017 7:51:53 AM |
Browse: 1128 |
Download: 999
12
Current management of talar osteochondral lesions
1/10/2017 4:10:00 PM |
Browse: 936 |
Download: 1053
13
Treatment of pregnant women with a diagnosis of inflammatory bowel disease
10/31/2016 9:01:00 AM |
Browse: 1291 |
Download: 1446
14
Cost-effectiveness of Crohn’s disease post-operative care
3/29/2016 3:29:00 PM |
Browse: 859 |
Download: 1344
15
Novel strategies for the treatment of diabetic macular edema
3/4/2016 3:35:00 PM |
Browse: 1095 |
Download: 1730
16
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs
12/2/2015 12:01:00 PM |
Browse: 1543 |
Download: 1359
17
Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management
11/12/2015 7:10:00 PM |
Browse: 1263 |
Download: 1698
18
Is non-biological treatment of rheumatoid arthritis as good as biologics?
3/19/2015 6:29:00 PM |
Browse: 1074 |
Download: 1180
19
Small intestinal bacterial overgrowth in inactive Crohn’s disease: Influence of thiopurine and biological treatment
10/16/2014 3:53:00 PM |
Browse: 1272 |
Download: 1562
20
Impact of medical therapy on patients with Crohn’s disease requiring surgical resection
9/7/2014 1:30:00 PM |
Browse: 1081 |
Download: 930
21
Inflammatory pathways of importance for management of inflammatory bowel disease
9/4/2014 5:33:00 PM |
Browse: 1348 |
Download: 1139
22
Prevention of post-operative recurrence of Crohn’s disease
9/3/2014 2:27:00 PM |
Browse: 1031 |
Download: 595
23
Development of systemic therapy for hepatocellular carcinoma at 2013: Updates and insights
9/1/2014 11:02:00 AM |
Browse: 987 |
Download: 987
24
From conception to delivery: Managing the pregnant inflammatory bowel disease patient
8/29/2014 5:07:00 PM |
Browse: 819 |
Download: 621
25
Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease
8/25/2014 2:47:00 PM |
Browse: 973 |
Download: 750
Page 1 of 1 ( 25 items )
<<
1
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345